HARROW, INC. — Director's Dealing 2009

Oct 16, 2009

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2009-10-12

Reporting Person: Schupp Joachim PH (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nonqualified Stock Option (Right to Buy)	$1.6	2019-06-18	Common Stock (85000)		Direct

Footnotes

F1: The option shall vest and become exercisable in accordance with the following schedule: (a) 25,000 of the underlying shares vest on October 6, 2009 and (b) 15,000 of the underlying shares vest each quarter thereafter, commencing after June 1, 2009, subject to continuous service.